4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-045137
Chief Financial Officer bought 20,000 shares at $0.26 ($5,198)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moran Sean F. Chief Financial Officer | 2022-08-10 | Purchase | +20,000 | $0.26 | $5,198 | 199,272 | D: show line 1 in the form |
| Open-market purchases · 20,000 sh · avg $0.26 · $5,198 | |||||||
Loading xslF345X03/doc4.xml…